QualityDipStocks / Real Estate · REITs
CareTrust REIT CTRE
Outside our quality screen, so we don’t track its dips. It’s 16% below its 52-week high.
Outside our quality screen. No fair value estimate for now: there isn’t enough data.
- Fair value est.
- n/a
- Market Value
- forming
- Off 52-wk high
- −16%
- Risk vs market
- Lowbeta −0.04
4 bullish · 4 bearish See why
Key levels
Every level vs today’s $36.39
- 52-wk lowlowest close, 1 year$34.35−5.6%
- PriceFri Oct 30 close$36.39you are here
- 52-wk highhighest close, 1 year$43.40+19.3%
Fair value estimate
No estimate for CTRE: Capital spending isn't tagged for the latest period in SEC XBRL data. We’d rather show nothing than a made-up number.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 30 to Oct 30, 252 sessions). Beta = how much CTRE moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Has moved mostly independently of the market, but its own price swings are 1.9× the S&P 500’s (it moves on its own news).
- Beta vs S&P 500
- -0.04
- Volatility
- 25% vs 13% SPY
- Correlation SPY
- −0.02
- Correlation QQQ
- −0.12
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 4 of 5
GrowthSales grew 53% to $571M over the last 12 months vs the 12 months before (SEC filings).
GrowthDiluted EPS grew 96% to $1.57 in FY2025.
GrowthSales compounded 34% a year from FY2022 to FY2025.
Cash returnsDividend yield of 3.5% ($305M paid over 12 months, 86% of earnings).
Top bearish points 4 of 5
Cash returnsShare count up 21.5% in a year: existing holders are being diluted.
Cash returnsDividends take 86% of earnings ($305M paid over 12 months), leaving little to reinvest or raise the payout.
QualityDoesn’t pass our quality screen: ROE under 12% and ROIC under 10%.
RiskReports earnings Nov 5 (consensus EPS $0.52): results can move the price sharply and reset Market Value.
Who’s talking about it
Notable investors, executives, analysts and public figures on CareTrust REIT in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 1, 9:09 PM ET.
Compare with peers
Closest in size in REITs
All fundamentals
P/E 24.2 · ROE 9% · Sales +53%
Valuation
- P/E
- 24.2×Real Estate median 28.7×
- Price / FCF
- n/anot reported in its SEC filings
- FCF yield
- n/anot reported in its SEC filings
- EV / EBITDA
- n/aD&A or debt not tagged in SEC data
- Price / sales
- 15.05×
- Price / book
- 1.91×
- Market cap
- $8.6Blisted
- Enterprise value
- $9.8B
Growth
- Revenue, 12 months
- $571M
- Sales growth, 12 months
- +53.0%vs the 12 months before
- Sales growth, 3 yrs
- +34.4%/yrfrom FY2022
- Diluted EPS, 12 months
- $1.61
- EPS growth, last FY
- +96.2%
- Net income, 12 months
- $355M
- Net income growth
- +62%12 months vs before
Profitability
- Gross margin
- n/agross profit isn't reported (common for service and financial companies)
- Operating margin
- n/anot reported in its SEC filings
- Net margin
- 62.1%
- FCF margin
- n/anot reported in its SEC filings
- Return on equity
- 9%
- Return on invested capital
- n/aoperating income, debt, equity or cash not tagged
Balance sheet
- Cash & short-term inv.
- $48M
- Total debt
- $1.2B
- Net cash
- −$1.2B
- Debt / equity
- 0.27×
- Interest coverage
- n/ainterest expense not tagged in SEC data
Cash flow & returns
- Free cash flow, 12 months
- n/anot reported in its SEC filings
- FCF growth, 12 months
- n/anot reported in its SEC filings
- Dividend yield
- 3.55%$305M paid
- Payout ratio
- 86%
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- +21.5%diluted shares vs a year ago
- Stock-based comp
- $11M
Trailing 12 months to Jun 30, 2026; balance sheet at Jun 30, 2026. From CareTrust REIT’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
Valuation details
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Momentum & 52-week range
RSI 48 · 5 days −0.6%
The business
FCF $-0.1B · Sales +44%
- Free cash flow, 12 months−$0.1B
- Free-cash-flow yield−0.9%
- Free-cash-flow margin−14%
- Gross margin96%
- Operating margin65%
- Return on invested capital5%
- Return on equity9%
- Sales growth (latest quarter vs year-ago quarter)+44%
- Net debt / EBITDA2.4×
Next report
Nov 5
- DateThu Nov 5, after the close
- Consensus EPS$0.52
- Year-ago EPS$0.45
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.
CTRE is outside our quality screen
One text when a published rule fires on one of the 333 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.